#

Small caps

: 1089
Equillium is testing its drug itolizumab across multiple indications. / Photo: Shutterstock
Small Caps·
Announced successful drug trials boost micro cap Equillium by 33%
Teladoc is acquiring a competitor to expand its offering. / Photo: teladochealth.com
Small Caps·
Virtual healthcare provider Teladoc to acquire competitor; shares jump 6%
Mobile personalization provider Zedge is restructuring its business. / Photo: youtube.com/@TechnoGenuine
Small Caps·
Emoji encyclopedia creator Zedge gains amid cost reductions
Sidus Space shares surged on the news before giving back some of the gains. / Photo: Sidus Space
Small Caps·
Space-as-a-service company Sidus jumps ahead of third satellite launch
MAIA’s oncology therapy is meant to destroy cancer cells from within. / Photo: shutterstock
Small Caps·
Biotech small cap MAIA jumps on positive trial data for its cancer drug
Protalix Biotherapeutics treatment for Gaucher disease uses an enzyme cultivated in carrot cell cultures (pictured). / Photo: protalix.com
Small Caps·
Micro-cap Protalix Biotherapeutics, focused on rare diseases, has 500% upside — Zacks SCR
Triumph manufactures aerospace components for major industry players, such as Boeing. / Photo: x.com /TriumphGroup
Small Caps·
Aerospace supplier Triumph Group jumps on news of its being acquired 
Around 80% of avocados sold in the U.S. come from Mexico. / Photo: Unsplash/Kelly Sikkema
Small Caps·
Avocado supplier stocks slide after U.S. tariff announcement, rebound slightly after truce with Mexico
EVgo stock fell following Donald Trumps victory in the presidential election, but the Motley Fool believes investors should take advantage of the decline.  / Photo: evgo.com
Small Caps·
The Motley Fool highlights reasons to buy EVgo stock despite Trump's stance on EVs
Pharma-Bio Serv recently reported fiscal-2024 results. / Photo: Shutterstock
Small Caps·
Zacks SCR says micro-cap Pharma-Bio Serv has 150% upside
One of the holdings, Cantaloupe, benefits from a growing number of self-service points. / Photo: Cantaloupe.com
Small Caps·
Royce Growth Fund manager names two 'high-confidence' small-cap holdings
Piper Sandler’s chief market technician expects small-cap stocks to outperform in 2025. / Photo: REUTERS /Andrew Kelly
Small Caps·
Piper Sandler expects the Russell 2000 to outperform the S&P 500 in 2025
Load more